Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$137.72 USD

137.72
562,365

+1.77 (1.30%)

Updated Jul 16, 2024 04:00 PM ET

After-Market: $137.80 +0.08 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

Top Ranked Growth Stocks to Buy for January 3rd

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 3rd.

Should Value Investors Buy DaVita HealthCare (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Top Ranked Growth Stocks to Buy for December 30th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 30th.

Top Ranked Growth Stocks to Buy for December 27th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 27th

Trina Mukherjee headshot

Rosy Outlook for Outpatient and Home Healthcare Industry

Growth prospects look bright for the Zacks Outpatient and Home Healthcare industry, thanks to AI, cost effectiveness and participation in APM.

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

Top Ranked Growth Stocks to Buy for December 24th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 24th

U.S. Consumer Spending Bolsters Economic Growth: 5 Picks

U.S. Consumer spending rises in November and with consumer sentiments' higher in December, these five stocks are a good buy.

DaVita HealthCare (DVA) Gains But Lags Market: What You Should Know

DaVita HealthCare (DVA) closed the most recent trading day at $73.75, moving +0.41% from the previous trading session.

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

The Zacks Analyst Blog Highlights: Amedisys, Select Medical Holdings, LHC, Eurofins Scientific and DaVita

Sapna Bagaria headshot

5 Healthcare Stocks to Keep the Winning Streak Alive in 2020

Increasing incidence of chronic diseases, aging U.S. population, innovation and consolidation will drive the healthcare industry's growth in 2020.

Top Ranked Growth Stocks to Buy for December 17th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 17th

Is DaVita HealthCare (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Why Is DaVita HealthCare (DVA) Up 2.9% Since Last Earnings Report?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Option Care Health (BIOS) Surges: Stock Moves 7.3% Higher

Option Care Health (BIOS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Top Ranked Growth Stocks to Buy for December 5th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 5th:

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita HealthCare (DVA) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: Samsung, Target and Davita

The Zacks Analyst Blog Highlights: Samsung, Target and Davita

John Blank headshot

A Holiday-Shortened Global Week Ahead

This is going to be a short trading week in the USA. Chief Strategist John Blank doesn't see much in the way of market moving events. Here are Reuters' latest five world market themes, reordered into relative importance for equity traders.

The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger

The Zacks Analyst Blog Highlights: Amedisys, DaVita, Tenet and Hanger

The Zacks Analyst Blog Highlights: DaVita, Quanta Services, CRA International, NRG Energy and First American Financial

The Zacks Analyst Blog Highlights: DaVita, Quanta Services, CRA International, NRG Energy and First American Financial

Manaswita Ghosh Dutta headshot

4 Healthcare Stocks to Gain From Stellar Q3 Earnings

Prominent activities in the healthcare sector are pushing the sector ahead this quarter.